Stay updated with breaking news from Nasdaq Phio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Phio Pharmaceuticals (NASDAQ:PHIO – Free Report) in a report published on Wednesday morning, Marketbeat reports. They currently have a $6.00 target price on the stock. HC Wainwright also issued estimates for Phio Pharmaceuticals’ Q3 2023 earnings at ($1.43) EPS, Q4 2023 earnings at ($0.81) EPS, FY2023 […]
Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) saw a large growth in short interest in July. As of July 15th, there was short interest totalling 30,000 shares, a growth of 18.1% from the June 30th total of 25,400 shares. Based on an average trading volume of 487,600 shares, the days-to-cover ratio is presently 0.1 […]
Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totalling 25,400 shares, a drop of 71.9% from the June 15th total of 90,300 shares. Approximately 1.7% of the company’s stock are sold short. Based on an […]
Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Rating) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 103,300 shares, a growth of 588.7% from the May 15th total of 15,000 shares. Based on an average daily volume of 564,200 shares, the days-to-cover ratio is […]
Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Rating) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 15,000 shares, a decline of 49.8% from the April 30th total of 29,900 shares. Approximately 1.0% of the shares of the company are sold short. Based on […]